G6PD and renal cell carcinoma: Nevertheless, given the fact that only 4% of ccRCCs present with p53 mutations, enhanced G6PD activities to direct glucose toward biosynthesis and increased tumor cells growth may not be due to p53 inactivation in RCC [46].